Fibromyalgia, Primary Terminated Phase 3 Trials for Cyclobenzaprine (DB00924)

Also known as: Primary Fibromyalgia

IndicationStatusPhase
DBCOND0040225 (Fibromyalgia, Primary)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02589275A 3-Month Open-Label Safety and Efficacy Study of TNX-102 SL Tablets in Fibromyalgia PatientsTreatment